| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0399-8320(06)73512-6 |
| P698 | PubMed publication ID | 17075479 |
| P2093 | author name string | Dominique Elias | |
| Michel Ducreux | |||
| Diane Goéré | |||
| Marc Pocard | |||
| Bruno Raynard | |||
| Delphine Rouquie | |||
| Ferechte Farkhondeh | |||
| Raoul Ciuchendea | |||
| P2860 | cites work | Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer | Q33810043 |
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer | Q33994410 | ||
| Peritonectomy procedures | Q34316366 | ||
| Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. | Q34407614 | ||
| Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. | Q40698258 | ||
| Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis | Q41741362 | ||
| Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma | Q42650727 | ||
| Measuring postoperative complications in general surgery patients using an outcomes-based strategy: comparison with complications presented at morbidity and mortality rounds | Q43737616 | ||
| Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution | Q43910359 | ||
| Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding | Q44388072 | ||
| Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients | Q44865285 | ||
| Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance | Q45059053 | ||
| Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. | Q55067760 | ||
| Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect | Q60629731 | ||
| Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer | Q68604488 | ||
| Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C | Q70369682 | ||
| Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination | Q71110208 | ||
| Peritoneal carcinomatosis from adenocarcinoma of the colon | Q71140778 | ||
| Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells | Q71976272 | ||
| Peritoneal carcinomatosis from colorectal cancer | Q78553388 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Long-term survival of peritoneal carcinomatosis of colorectal origin | Q81645274 | ||
| P433 | issue | 10 | |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 1200-1204 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Gastroenterologie Clinique et Biologique | Q15756157 |
| P1476 | title | Peritoneal carcinomatosis of colorectal origin | |
| P478 | volume | 30 |
| Q42257413 | A case report of surgical resections with local and systemic chemotherapy for three recurrences of colon cancer occurring ten years after colectomy |
| Q86992785 | Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis |
| Q47569322 | Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion |
| Q37094755 | Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis |
| Q40355978 | Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. |
| Q43037375 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies |
| Q41547533 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence |
| Q34819493 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center |
| Q50002298 | Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations |
| Q35445073 | Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms |
| Q38027521 | Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases |
| Q46827170 | Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy |
| Q58766340 | Peritoneal carcinomatosis |
| Q34391090 | Peritoneal carcinomatosis of colorectal origin. |
| Q45839982 | Peritoneal carcinomatosis of colorectal origin: results of cytoreductive surgery with peritonectomy and hyperthermic intraoperative chemotherapy |
| Q45193745 | Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy |
| Q92454477 | Pharmacokinetic Profile and Anti-Adhesive Effect of Oxaliplatin-PLGA Microparticle-Loaded Hydrogels in Rats for Colorectal Cancer Treatment |
| Q85855891 | Preclinical antitumor activity of a nanoparticulate SN38 |
| Q35974935 | Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. |
| Q55688974 | Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. |
| Q33931049 | Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases |
| Q60948065 | Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer |
| Q92086470 | Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial |
| Q43136067 | The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin |
| Q81415692 | [Treat the peritoneum with respect! It's our first line of defense against carcinomatosis] |
Search more.